Compstatin Analogs With Increased Solubility And Improved Pharmacokinetic Properties. Type: Application. Issued: January 28, 2020 (US Patent #10,800,812. Inventors: John D. Lambris.
Modified Compstatin with Improved Stability and Binding Properties (Thioether). Type: Application. Issued: April 24, 2014. Inventors: J.D. Lambris, and W. van der Donk.
Complement-Mediated Thrombophilic Assay.(US Patent #8563259). Issued: October 22, 2013. Inventors: J.D. Lambris and K. Ritis.
Compstatin Analogs with Improved Pharmacokinetic Properties. Type: Application. Issued: June 11, 2015. Inventors: J.D. Lambris, H. Qu, and D. Ricklin.
Complement Inhibitors as Therapeutic Agents for Treatment of Cancer. Type: Application. Issued: February 24, 2011. Inventors: J.D. Lambris and M. Markiewski.
Complement Inhibitors for Treatment of Injury from Intracebral Hemorrhage. Type: Application. Issued: October 20, 2011. Inventors: J.D. Lambris and S.E. Connolly.
Compositions and Methods for Inhibiting Inducible T Cell Kinase (ITK) and Treating Asthma and Bronchial Inflammations. Type: Application. Issued: November 11, 2010. Inventors: K. Tsoukas and J.D. Lambris.
Compstatin Analogs with Improved Activity. Type: Grant (US Patent #8883413). Issued: November 11, 2014. Inventors: J.D. Lambris.
Compstatin Analogs with Improved Activity. Type: Application. Issued: June 11, 2015. Inventors: J.D. Lambris.
Compstatin Analogs with Improved Activity. Type: Grant(US Patent #7989589). Issued: August 2, 2011. Inventors: J.D. Lambris.
Compstatin Analogs with Increased Solubility and Improved Pharmacokinetic Properties. Pending. Inventors: J.D. Lambris.
Factor H Binding Peptides and Uses Thereof. Type: Grant (US Patent #8962795). Issued: February 24, 2015. Inventors: J. D. Lambris.
Regulator of Complement Activation and Uses Thereof. Type: Grant (US Patent #9540626). Issued: January 10, 2017. Inventors: J.D. Lambris, D. Ricklin, and C.Q. Schmidt.
Method of Inhibiting Biomaterial-Induced Procoagulant Activity Using Complement Inhibitors. Type: Grant (US Patent #8445190). Issued: May 21, 2013. Inventors: J.D. Lambris and K. Ritis.
Method of Reducing Tissue Loss in Pancreatic Islet Cell Transplantation. Type: Application. Issued: January 13, 2011. Inventors: J.D. Lambris, O. Korsgren, and B. Nillson.
Method of Treating Respiratory Acute Distress Syndrome. Type: Application. Issued: June 16, 2011. Inventors: J.D. Lambris, and K. Ritis.
Methods of Treating or Preventing Periodontitis and Diseases Associated with Periodontitis. Type: Application. Issued: December 26, 2013. Inventors: G. Hajishengallis and J.D. Lambris.
Methods of Treating or Preventing Periodontitis and Diseases Associated with Periodontitis. Type: Application. Issued: February 7, 2013. Inventors: G. Hajishengallis and J.D. Lambris.
Modified Compstatin with Peptide Backbone and C-Terminal Modifications. Type: Grant (US Patent #8946145). Issued: July 23, 2015. Inventors: J.D. Lambris and H. Qu.
Peptides for Inhibition of Herpes Simplex Virus Entry. Type: Grant (US Patent #6699481). Issued: March 2, 2004. Inventors: J.D. Lambris, M.R. Sarrias, G.H. Cohen, P.G. Spear, and R.I. Mongomery.
Peptides for Inhibition of Herpes Simplex Virus Entry. Type: Application. Issued: December 23, 2004. Inventors: J.D. Lambris, M.R. Sarrias, G.H. Cohen, R.J. Eisenberg, P.G. Spear, and R.I. Montgomery.
Peptides which Inhibit Complement Activation. Type: Grant(US Patent #6319897). Issued: November 20, 2001. Inventors: J.D. Lambris and A. Sahu.
Potent Compstatin Analogs. Type: Grant (US Patent #7888323). Issued: February 15, 2011. Inventors: J.D. Lambris and M. Katragadda.
Regulator of Complement Activation and Uses Thereof. Type: Application. Issued: April 23, 2015. Inventors: J.D. Lambris, C. Schmidt, and D. Ricklin.
Secreted Staphylococcus Aureus Proteins and Peptides for Use in Inhibiting Activation of the Complement System. Type: Application. Issued: February 24, 2011. Inventors: J.D. Lambris and B.V. Geisbrecht.
Structure of Compstatin-C3 Complex and Use for Rational Drug Design. Type: Grant (US Patent #8442776). Issued: May 14, 2013. Inventors: J.D. Lambris, B.J.C. Janssen, and P. Gros.
Treatment of Colon Cancer Using Complement Inhibitors. Type: Application. Issued: August 7, 2014. Inventors: J.D. Lambris, J. Nadeau, S. Doerner, and N. D. Berger.
Treatment of Sepsis Using Complement Inhibitors. Type: Application. Issued: February 28, 2013. Inventors: J.D. Lambris, F. B. Taylor, F. Lupu, and G. Kinasewitz.
Click here for Published Patents and Applications.
